The trust alleged the board of directors failed in their oversight of Insys executives, who engaged in off-label marketing of its fentanyl spray, called Subsys, and paid bribes and kickbacks to doctors.
April 14, 2023 at 07:40 PM
4 minute read
The original version of this story was published on Delaware Law Weekly
A liquidation trust for Insys Therapeutics Inc. reached a $175 million settlement with the opioid manufacturer’s former board of directors.
The trust, in a draft complaint, alleged that the board of directors failed in their oversight of Insys executives, who engaged in off-label marketing of its fentanyl spray, called Subsys, and paid bribes and kickbacks to doctors.
Presented by BigVoodoo
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
A large and well-established Tampa company is seeking a contracts administrator to support the company's in-house attorney and manage a wide...
We are seeking an attorney to join our commercial finance practice in either our Stamford, Hartford or New Haven offices. Candidates should ...
We are seeking an attorney to join our corporate and transactional practice. Candidates should have a minimum of 8 years of general corporat...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
INSYS Therapeutics logo on the website homepage.
